高危患者主动脉弓烟囱支架辅助TEVAR的结局
结果显示技术成功率为89%,30天死亡率为4%,1年与3年生存率分别为88%±6%和69%±9%;非计划放置AAC与卒中风险升高相关,且主动脉相关再干预并不少见。
要点
- 高危主动脉弓疾病患者行AAC辅助TEVAR技术成功率高,30天死亡率低。
- 非计划放置AAC可能导致卒中风险升高。
- 中期生存可接受,但主动脉相关再干预常见,需密切随访。
核心结论
- 在高危患者中,AAC辅助TEVAR技术成功率高,并发症率和死亡率可接受。
- 非计划放置AAC导致卒中风险升高,可能与需要覆盖分支血管有关。
- 中期生存可接受,但主动脉相关再干预并不少见,需要 diligent 随访。
研究设计与样本
- 回顾性分析2002至2015年所有TEVAR手术,筛选出使用AAC支架的患者。
- 主要终点为技术成功、30天和1年死亡率;次要终点包括并发症、再干预和内漏。
主要发现
- 技术成功率为89%(1例术中死亡,2例随访中持续Ia型内漏)。
- 30天死亡率为4%(n=1,为破裂性弓部动脉瘤患者术中死亡),中位住院时间为6天(IQR 4-9)。
- 7例(26%)患者发生主要并发症:卒中3例(均为非计划放置头臂干烟囱支架)、呼吸衰竭3例、死亡1例。
- 9例(33%)患者接受主动脉相关再干预,随访期间无烟囱支架闭塞事件(中位随访9个月,IQR 1-23)。
- 1年和3年生存率估计分别为88%±6%和69%±9%。
关键数值与推荐
- 技术成功定义为患者存活度过索引手术,AAC支架部署在预定治疗区域,且初始术后影像学无I型或III型内漏证据。
- 5例(19%)患者同时放置无名动脉-左颈总动脉烟囱支架。
- 计划放置头臂干烟囱支架占75%(n=24),其余因左颈总动脉或无名动脉受累而放置(n=8)。
临床怎么用
- 对于开放手术高风险的高危主动脉弓疾病患者,AAC辅助TEVAR是一种可行的微创治疗选择。
- 应尽量避免非计划放置AAC,以降低卒中风险。
- 术后需要密切随访,监测内漏、再干预需求及烟囱支架通畅情况。
局限性
- 随访时间中位数仅9个月,长期结果不确定。
- 缺乏对照组,无法直接比较AAC辅助TEVAR与开放手术或其他杂交技术的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic arch disease is a challenging clinical problem, especially in high-risk patients, in whom open repair can have morbidity and mortality rates of 30% to 40% and 2% to 20%, respectively. Aortic arch chimney (AAC) stents used during thoracic endovascular aortic repair (TEVAR) are a less invasive treatment strategy than open repair, but the current literature is inconclusive about the role of this technology. The focus of this analysis is on our experience with TEVAR and AAC stents. METHODS: All TEVAR procedures performed from 2002 to 2015 were reviewed to identify those with AAC stents. Primary end points were technical success and 30-day and 1-year mortality. Secondary end points included complications, reintervention, and endoleak. Technical success was defined as a patient's surviving the index operation with deployment of the AAC stent at the intended treatment zone with no evidence of type I or type III endoleak on initial postoperative imaging. The Kaplan-Meier method was used to estimate survival. RESULTS: Twenty-seven patients (age, 69 ± 12 years; male, 70%) were identified, and all were described as being at prohibitive risk for open repair by the treating team. Relevant comorbidity rates were as follows: coronary artery disease/myocardial infarction, 59%; oxygen-dependent emphysema, 30%; preoperative creatinine concentration >1.8 mg/dL, 19%; and congestive heart failure, 15%. Presentations included elective (67%; n = 18), symptomatic (26%; n = 7), and ruptured (7%; n = 2). Eleven patients (41%) had prior endovascular or open arch/descending thoracic repair. Indications were degenerative aneurysm (49%), chronic residual type A dissection with aneurysm (15%), type Ia endoleak after TEVAR (11%), postsurgical pseudoaneurysm (11%), penetrating ulcer (7%), and acute type B dissection (7%). Thirty-two brachiocephalic vessels were treated: innominate (n = 7), left common carotid artery (LCCA; n = 24), and left subclavian artery (n = 1). Five patients (19%) had simultaneous innominate-LCCA chimneys. Brachiocephalic chimney stents were planned in 75% (n = 24), with the remainder placed for either LCCA or innominate artery encroachment (n = 8). Overall technical success was 89% (one intraoperative death, two persistent type Ia endoleaks in follow-up). The 30-day mortality was 4% (n = 1; intraoperative death of a patient with a ruptured arch aneurysm), and median length of stay was 6 (interquartile range, 4-9) days. Seven (26%) patients experienced a major complication (stroke, three [all with unplanned brachiocephalic chimney]; respiratory failure, three; and death, one). Nine (33%) patients underwent aorta-related reintervention, and no chimney occlusion events occurred during follow-up (median follow-up, 9 [interquartile range, 1-23] months). The 1-year and 3-year survival is estimated to be 88% ± 6% and 69% ± 9%, respectively. CONCLUSIONS: TEVAR with AAC can be performed with high technical success and acceptable morbidity and mortality in high-risk patients. Unplanned AAC placement during TEVAR results in an elevated stroke risk, which may be related to the branch vessel coverage necessitating AAC placement. Acceptable midterm survival can be anticipated, but aorta-related reintervention is not uncommon, and diligent follow-up is needed.
引用
- Voskresensky I, Scali ST, Feezor RJ, et al. Outcomes of thoracic endovascular aortic repair using aortic arch chimney stents in high-risk patients. J Vasc Surg. 2017. PMID: 28216358. doi:10.1016/j.jvs.2016.11.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。